medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
188条
与
Carcinoma
有关的结果
Pembrolizumab for Treating Recurrent Or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-based Chemotherapy (Terminated Appraisal)
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
其他
|
头颈部肿瘤
National Institute for Health and Care Excellence
Squamous Cell
Carcinoma
Head and Neck
Pembrolizumab
指南简介
原文链接
SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
无
Adjuvant Chemotherapy
Bladder-sparing
Chemoradiation
Enhanced Recovery after Surgery
Muscle-invasive Bladder Cancer
Neoadjuvant Chemotherapy
Radical Cystectomy
Transurethral Resection of Bladder Tumor
Trimodal
Urothelial
Carcinoma
of Bladder
Variant Histology
指南简介
原文链接
Consultation on UTUC, Stockholm 2018 Aspects of Diagnosis of Upper Tract Urothelial Carcinoma
2019年 发布于
World J Urol
37卷 第11期
所属人体系统:
泌尿
|
膀胱肿瘤
无
CT Urography
Diagnostic Samples
Diagnostics
UTUC
Upper Tract Urothelial
Carcinoma
Ureteroscopy
指南简介
原文链接
Consensus on the Pathological Definition and Classification of Poorly Cohesive Gastric Carcinoma
2019年 发布于
Gastric Cancer
22卷 第1期
所属人体系统:
消化
|
胃癌
European Chapter of International Gastric Cancer Association
Gastric
Carcinoma
Pathological Definition
Classification
Consensus
指南简介
原文链接
British Society of Gastroenterology Guidelines on the Diagnosis and Management of Patients at Risk of Gastric Adenocarcinoma
2019年 发布于
Gut
68卷 第9期
所属人体系统:
消化
|
胃癌
British Society of Gastroenterology
Endoscopy
Gastric Adenocarcinoma
Gastric Pre-cancer
Gastritis
Helicobacter Pylori-gastritis
指南简介
原文链接
National Consensus Recommendations on Patient-centered Care for Ductal Carcinoma in Situ
2019年 发布于
Breast Cancer Res Treat
174卷 第3期
所属人体系统:
生殖
|
乳腺肿瘤
无
Consensus
Ductal
Carcinoma
in Situ
Patient-centered Care
Recommendations
指南简介
原文链接
Cabozantinib for Previously Treated Advanced Hepatocellular Carcinoma (Terminated Appraisal)
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
消化
|
肝肿瘤
National Institute for Health and Care Excellence
Hepatocellular
Carcinoma
treatment
Cabozantinib
指南简介
原文链接
Cabozantinib for Previously Treated Advanced Hepatocellular Carcinoma (Terminated Appraisal)
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
消化
|
肝肿瘤
National Institute for Health and Care Excellence
Hepatocellular
Carcinoma
treatment
Cabozantinib
指南简介
原文链接
Regorafenib for Previously Treated Advanced Hepatocellular Carcinoma
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
消化
|
肝肿瘤
National Institute for Health and Care Excellence
Hepatocellular
Carcinoma
treatment
Regorafenib
指南简介
原文链接
Ramucirumab for Treating Unresectable Hepatocellular Carcinoma after Sorafenib (Terminated Appraisal)
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
消化
|
肝肿瘤
National Institute for Health and Care Excellence
Hepatocellular
Carcinoma
treatment
Ramucirumab
指南简介
原文链接
The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma (RCC)
2019年 发布于
Journal for ImmunoTherapy of Cancer
7卷 第1期
所属人体系统:
泌尿
|
肾癌
Society for Immunotherapy of Cancer
Guidelines
Immune Checkpoint Inhibitor (ICI)
Immunotherapy
Kidney Cancer
Renal Cell
Carcinoma
(RCC)
指南简介
原文链接
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer
2019年 发布于
J Am Coll Radiol
16卷 第11S期
所属人体系统:
泌尿
|
肾癌
American College of Radiology
AUC
Appropriate Use Criteria
Appropriateness Criteria
CT
Diagnostic Imaging
MRI
Renal Cell
Carcinoma
Surveillance
Ultrasound
X-ray
指南简介
原文链接
Best Treatment Options for Advanced Renal Cell Carcinoma (RCC) Patients: a Delphi Consensus Study
2019年 发布于
Med Oncol
36卷 第3期
所属人体系统:
泌尿
|
肾癌
无
Cabozantinib
Delphi Study
Everolimus
Immunotherapy
Nivolumab
Renal Cell
Carcinoma
TKI.
指南简介
原文链接
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients with Renal Medullary Carcinoma
2019年 发布于
Clin Genitourin Cancer
17卷 第1期
所属人体系统:
泌尿
|
肾癌
无
INI1
Renal Cell
Carcinoma
SMARCB1
Sickle Hemoglobinopathies
Unclassified Renal Cell
Carcinoma
with Medullary Phenotype.
指南简介
原文链接
Kidney Cancer Research Network of Canada (KCRNC) Consensus Statement on the Role of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma
2019年 发布于
Canadian Urological Association Journal
13卷 第6期
所属人体系统:
泌尿
|
肾癌
Kidney Cancer Research Network of Canada
Metastatic Renal Cell
Carcinoma
Cytoreductive Nephrectomy
Consensus
指南简介
原文链接
European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update
2019年 发布于
Eur Urol
75卷 第5期
所属人体系统:
泌尿
|
肾癌
European Association of Urology
The European Association of Urology Renal Cell
Carcinoma
Guideline Panel Has Thoroughly Evaluated the Available Research Data on Kidney Cancer to Establish International Standards for the Care of Kidney Cancer Patients
指南简介
原文链接
Renal Cell Carcinoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up†
2019年 发布于
Ann Oncol
30卷 第5期
所属人体系统:
泌尿
|
肾癌
European Society for Medical Oncology
Renal Cell
Carcinoma
Diagnosis
Treatment
Follow-up
Guideline
指南简介
原文链接
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
2019年 发布于
Eur Urol
76卷 第2期
所属人体系统:
泌尿
|
肾癌
European Association of Urology
Cabozantinib
Guidelines
Immune Checkpoint Inhibitors
Ipilimumab
Metastatic
Nivolumab
Pazopanib
Renal Cell
Carcinoma
Sunitinib.
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a
Carcinoma
tosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a
Carcinoma
tosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介
原文链接
首页
上一页
1
2
3
4
5
6
7
8
9
10
下一页
尾页
共188条,每页显示
20条
50条
100条
跳转至第
页
确定